Marie-Paule Kieny, assistant director general at the United Nations health agency, said failure to disclose trial results led to misinformation and could result in skewed priorities for research and public health interventions. In recent years, the pharmaceuticals industry has gone a long way to commit to disclosing results for new clinical studies, but critics argue it is still not doing enough to ensure doctors have access to all drug data. The WHO also wants disclosure of older unreported clinical trials, the results of which may still have an important bearing on medical practice and scientific research today.
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment